Asep Medical

ASEP Medical Holdings Inc. is a Canada-based biotechnology company. The company, through its subsidiary ABT Innovations Inc., provides a range of peptide technologies for the treatment of various infectious diseases. It also offers diagnostic kits for predicting the onset of severe sepsis and organ failure through its subsidiary Sepset Biosciences Inc. The company has developed a diagnostic assay for the early and rapid diagnosis of sepsis, which is based on detecting immune response-specific molecular signatures of sepsis rather than the presence of pathogens. Additionally, it has developed peptide technology that directly addresses the ineffectiveness of current treatment options by inhibiting biofilm regeneration and reducing inflammation.